Press Releases
| All Releases |
 |
Barry Ginsberg, M.D., Ph.D. Elected to Biodel's Board of Directors
Jun 11, 2008
|
8.5 KB |
|
| |
DANBURY, Conn., June 11, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Barry Ginsberg, M.D., Ph.D., has been elected as a new member of its Board of Directors, effective June 10, 2008. Dr. Ginsberg is currently Chief Executive Officer of Diabetes Technology Consultants where he advises Fortun...
|
|
Biodel Inc. to Present at the Canaccord Adams Diabetes and Obesity Conference on June 6th 2008
Jun 4, 2008
|
8.0 KB |
|
| |
DANBURY, Conn., June 4, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Gerard Michel, Chief Financial Officer, Vice President of Corporate Development and Treasurer of Biodel, will present a corporate update at the Canaccord Adams Diabetes and Obesity Conference on Friday, June 6, 2008 at 1:40...
|
|
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
May 20, 2008
|
8.4 KB |
|
| |
DANBURY, Conn., May 20, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Alan Krasner, M.D. has been appointed as the Company's Chief Medical Officer, effective May 27, 2008.
"The addition of Dr. Krasner to our team provides Biodel with strong internal clinical and regulatory leadership and ...
|
|
Biodel Inc. to Present at the 2008 Citi Investment Research Global Healthcare Conference on May 22nd 2008
May 14, 2008
|
8.0 KB |
|
| |
DANBURY, Conn., May 14, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Gerard Michel, Chief Financial Officer, Vice President of Corporate Development and Treasurer of Biodel, will present a corporate update at the 2008 Citi Investment Research Global Healthcare Conference on Thursday, May 22,...
|
|
Biodel Inc. Added to NASDAQ Biotechnology Index
May 13, 2008
|
8.3 KB |
|
| |
DANBURY, Conn., May 13, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has been selected for inclusion in the NASDAQ Biotechnology Index (NBI), effective as of the market's open on Monday, May 19, 2008.
"We are pleased to be included in the NASDAQ Biotechnology Index and believ...
|
|
Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
May 9, 2008
|
17.6 KB |
|
| |
DANBURY, Conn., May 9, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for its second quarter ended March 31, 2008. The net loss for the quarter was $9.6 million or $0.43 per share.
"We remain on track in our development of VIAject(TM)," stated Dr. Solomon Steiner, CEO and Chair...
|
|
Biodel Inc. to Present at the Bank of America 2008 Health Care Conference on May 13th 2008
May 5, 2008
|
8.0 KB |
|
| |
DANBURY, Conn., May 5, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Gerard Michel, Chief Financial Officer, Vice President of Corporate Development and Treasurer of Biodel, will present a corporate update at the Bank of America Health Care Conference on Tuesday, May 13, 2008 at 9:20 a.m. Pac...
|
|
Biodel Inc. to Announce Second Quarter Fiscal Year 2008 Financial Results on May 9, 2008
Apr 29, 2008
|
8.2 KB |
|
| |
DANBURY, Conn., April 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that its second quarter fiscal year 2008 financial results will be released on Friday, May 9, 2008. Following the issuance of its financial results, Biodel's senior management team will host a conference call to discuss second...
|
|
Biodel Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference April 30th 2008
Apr 22, 2008
|
8.0 KB |
|
| |
DANBURY, Conn., April 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, CEO and Chairman of Biodel, will present a corporate update at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30, 2008 at 10:30 a.m. Eastern Time. The conference will be...
|
|
Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
Mar 20, 2008
|
8.0 KB |
|
| |
DANBURY, Conn., March 20, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Gerard Michel, Chief Financial Officer, Vice President of Corporate Development and Treasurer of Biodel, will present a corporate update at the BioCentury Future Leaders Conference on Thursday, March 27, 2008 at 3:00 p.m....
|
|
Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results
Feb 14, 2008
|
16.0 KB |
|
| |
DANBURY, Conn., Feb 14, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for its first quarter ended December 31, 2007. The net loss for the quarter was $11.0 million or $0.55 per share.
"Completing enrollment of our two pivotal Phase III clinical trials of VIAject(TM) positions ...
|
|
Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008
Feb 8, 2008
|
10.3 KB |
|
| |
DANBURY, Conn., Feb 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that its first quarter fiscal year 2008 financial results will be released on Thursday, February 14, 2008. Following the issuance of its financial results, Biodel's senior management team will host a conference call to discuss f...
|
|
Biodel Inc. Announces Pricing of Public Offering
Feb 7, 2008
|
7.3 KB |
|
| |
DANBURY, Conn., Feb 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced the pricing of the underwritten public offering of 3,810,000 shares of its common stock at a price to the public of $15.50 per share. Of the shares being sold in the offering, 3,260,000 shares are being issued and sold by Biodel...
|
|
Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
Jan 3, 2008
|
10.5 KB |
|
| |
DANBURY, Conn., Jan 03, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has completed enrollment of its two pivotal Phase III clinical trials of VIAject(TM), a rapid-acting injectable meal-time insulin for use by patients with Type 1 and Type 2 diabetes. The Company also announced i...
|
|
Biodel Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 7th, 2008
Dec 21, 2007
|
10.1 KB |
|
| |
DANBURY, Conn., Dec 21, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the 26th Annual JPMorgan Healthcare Conference on Monday, January 7, 2008 at 2:30 p.m. Pacific Time.
The JPMorgan Healthcare Conference...
|
|
Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Dec 11, 2007
|
19.0 KB |
|
| |
DANBURY, Conn., Dec 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today reported fourth quarter and fiscal year ended September 30, 2007 financial results, updated pipeline progress and disclosed 2008 objectives.
"In 2007, our first year as a public company, we advanced our pipeline and achieved critical ...
|
|
Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007
Dec 5, 2007
|
10.3 KB |
|
| |
DANBURY, Conn., Dec 05, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that it will issue its fourth quarter and fiscal year 2007 financial results on December 11, 2007. Following the issuance of its financial results, Biodel's senior management team will host a conference call to discuss the resul...
|
|
Brian J.G. Pereira, M.D. Joins Biodel's Board of Directors
Nov 21, 2007
|
11.1 KB |
|
| |
DANBURY, Conn., Nov 21, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel, Inc. (Nasdaq: BIOD) today announced the addition of Brian J.G. Pereira, M.D., to its Board of Directors.
Dr. Pereira is the President and CEO of AMAG Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of ther...
|
|
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Nov 14, 2007
|
10.2 KB |
|
| |
DANBURY, Conn., Nov 14, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Gerard Michel has been appointed as the Company's Chief Financial Officer, Vice President of Corporate Development and Treasurer, effective November 20, 2007.
"We are pleased to welcome Gerard to our team," said Dr. Sol...
|
|
Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007
Oct 4, 2007
|
9.1 KB |
|
| |
DANBURY, Conn., Oct 04, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the BIO InvestorForum 2007 in San Francisco, CA on October 11th at 11:00 AM PT.
Interested parties may access a link to a live audio webcas...
|
|
|
= add release to Briefcase
|
Print Page
Email Page